Endo International
Based in PA
AI Overview
With $3.3M in lobbying spend across 24 quarterly filings, Endo International is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $450K |
| 2019 | $560K |
| 2020 | $560K |
| 2021 | $560K |
| 2022 | $700K |
| 2023 | $420K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Endo International disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
Issues related to Medicare reimbursement of pharmaceuticals and the Inflation Reduction Act; Issues related to FDA policy; Issues related to implementation of the Bipartisan Infrastructure Law
Issues relating to rulemaking around Single-use Package Drugs; Issues related to implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.